Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-12-02T21:38:18.403Z Has data issue: false hasContentIssue false

P.030 Remote ischemic conditioning in acute ischemic stroke and small vessel disease – a feasibility study

Published online by Cambridge University Press:  24 May 2024

A Majeed
Affiliation:
(Edmonton)*
N Khan
Affiliation:
(Edmonton)*
G Bhangoo
Affiliation:
(Edmonton)
M Kate
Affiliation:
(Edmonton)
A Shuaib
Affiliation:
(Edmonton)
B Buck
Affiliation:
(Edmonton)
V Mushahwar
Affiliation:
(Edmonton)
M Ferguson-Pell
Affiliation:
(Edmonton)
RJ Sarmiento
Affiliation:
(Edmonton)
R Kadangot
Affiliation:
(Edmonton)
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: We tested the hypothesis that delivering remote ischemic conditioning (RIC) with an adjunct tissue reflectance sensor (TRS) device may be feasible in patients with acute ischemic stroke (AIS) and cerebral small vessel disease (cSVD). Methods: AIS patients with neurological deficits within 7 days of symptom onset were screened for moderate to severe cSVD. Eligible patients were randomized 2:1 to receive intervention RIC or sham RIC (7 days). The primary outcome measure was intervention feasibility. It was assessed as an intervention-related comfort by a 5-point Likert scale during each session (1-very uncomfortable, 5-very comfortable). The secondary outcome measure was assessment of TRS derived dermal blood concentration and blood oxygenation changes during RIC. Results: Forty-seven (32 intervention, 15 sham) patients were enrolled at a median (IQR) 39.7 (25-64) hours after symptom onset, with mean±SD age of 75±12 years, 22 (46.8%) were females and median baseline NIHSS of 5(3-7). The Likert scale was 3.5 (3-4) in the intervention group and 4 (4-5) in the sham group. The TRS derived blood concentration and blood oxygenation changes were proportionate in the intervention arm and absent in the sham arm. Conclusions: RIC treatment with TRS is feasible in patients with AIS+cSVD. The efficacy of RIC needs further assessment.

Type
Abstracts
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation